Lift Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 17

Lift Therapeutics General Information

Description

Developer of a biotech platform designed for CAR neutrophil cell therapy that helps overcome the limitations of current therapies in solid tumors. The company's platform offers immunomodulatory alpha neutrophils (IMANs) that turn the tumor microenvironment and recruit the rest of the immune system to destroy the lasting immunity by using stem cells, which is a proprietary media and genetic engineering, enabling healthcare providers to use CAR-IMAN cells to give patients potentially the cancer-killing ability they naturally possess.

Contact Information

Website
www.lift-tx.com
Formerly Known As
LIfT BioSciences Limited
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • London BioScience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • London BioScience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom

Lift Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lift Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Accelerator/Incubator 19-Jan-2026 Completed Pre-Clinical Trials
13. Grant 29-Jul-2025 Completed Pre-Clinical Trials
12. Later Stage VC (Series A) 07-May-2024 Completed Pre-Clinical Trials
11. Grant 09-Oct-2024 Completed Pre-Clinical Trials
10. Accelerator/Incubator 01-Sep-2023 Completed Pre-Clinical Trials
9. Later Stage VC 01-Mar-2023 Completed Pre-Clinical Trials
8. Seed Round 17-Jan-2022 Completed Pre-Clinical Trials
7. Later Stage VC (Series A) 01-Apr-2020 Cancelled Pre-Clinical Trials
6. Seed Round 15-Jan-2020 $699K $3.18M Completed Pre-Clinical Trials
5. Accelerator/Incubator 12-Feb-2019 $961K $2.48M Completed Pre-Clinical Trials
To view Lift Therapeutics’s complete valuation and funding history, request access »

Lift Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Preferred Shares
Series A Preferred Shares
Seed-2 Preferred Shares
Seed-2 Preferred Shares
Seed-1 Preferred Shares
Ordinary
Ordinary 1,596 $0.012495 $639.74 $639.74 1x $639.74 4.4%
Ordinary 1,290 $0.012495 $624.75 $624.75 1x $624.75 3.56%
To view Lift Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lift Therapeutics Patents

Lift Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202413837-D0 Combinatorial treatment Inactive 19-Sep-2024
WO-2026062398-A1 Combinatorial treatment Pending 19-Sep-2024
GB-202413845-D0 Granulocytes and granulocyte precursors Inactive 19-Sep-2024
WO-2026062399-A1 Granulocytes and granulocyte precursors Pending 19-Sep-2024
GB-202413835-D0 Preparation of cells Inactive 19-Sep-2024
To view Lift Therapeutics’s complete patent history, request access »

Lift Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lift Therapeutics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Japan External Trade Organization Accelerator/Incubator
Department of Enterprise, Trade and Employment Government
ScaleReady Corporation
Sijbrandij Foundation Corporation Minority
Grow London Accelerator/Incubator
You’re viewing 5 of 17 investors. Get the full list »

Lift Therapeutics FAQs

  • When was Lift Therapeutics founded?

    Lift Therapeutics was founded in 2014.

  • Where is Lift Therapeutics headquartered?

    Lift Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Lift Therapeutics?

    Lift Therapeutics has 22 total employees.

  • What industry is Lift Therapeutics in?

    Lift Therapeutics’s primary industry is Biotechnology.

  • Is Lift Therapeutics a private or public company?

    Lift Therapeutics is a Private company.

  • What is Lift Therapeutics’s current revenue?

    The current revenue for Lift Therapeutics is .

  • How much funding has Lift Therapeutics raised over time?

    Lift Therapeutics has raised $21.8M.

  • Who are Lift Therapeutics’s investors?

    Japan External Trade Organization, Department of Enterprise, Trade and Employment, ScaleReady, Sijbrandij Foundation, and Grow London are 5 of 17 investors who have invested in Lift Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process